Literature DB >> 12110029

A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients.

Angela Yee-Moon Wang1, Mei Wang, Jean Woo, Man-Ching Law, Kai-Ming Chow, Philip Kam-Tao Li, Siu-Fai Lui, John Elsby Sanderson.   

Abstract

BACKGROUND: Left ventricular hypertrophy (LVH) and dialysis adequacy are both important predictors for mortality in dialysis patients. This study evaluated the association between residual renal function (RRF) and the severity of LVH in endstage renal failure (ESRF) patients undergoing long-term continuous ambulatory peritoneal dialysis (CAPD).
METHODS: A cross-section study was performed with left ventricular mass index (LVMi), determined in 158 non-diabetic CAPD patients using echocardiography and its relationship with residual glomerular filtration rate (GFR), peritoneal dialysis (PD) and total weekly urea clearance (Kt/V) and other known risk factors for LVH was evaluated.
RESULTS: Twelve patients had no LVH (group I). The remaining 146 patients were stratified [group II (lowest), III and IV (highest)] according to the LVMi (median 207 g/m2; range 103 to 512 g/m2). Across the four groups of patients with increasing LVMi, there was significant decline in GFR (2.27 +/- 1.98 vs. 1.49 +/- 1.58 vs. 1.61 +/- 1.91 vs. 0.80 +/- 1.42 mL/min/1.73 m2; P = 0.011) and total weekly Kt/V (1.98 +/- 0.44 vs. 1.96 +/- 0.38 vs. 1.92 +/- 0.42 vs. 1.71 +/- 0.42; P = 0.037); however, PD Kt/V was similar for all four groups. Patients with better-preserved residual GFR not only had significantly higher total Kt/V, but were less anemic and hypoalbuminemic and had a trend toward lower systolic blood pressure and arterial pulse pressure. Multiple regression analysis showed that other than age, gender, body weight, arterial pulse pressure, hemoglobin and serum albumin, known factors for LVH, residual GFR (estimated mean -7.94; 95% confidence interval -15.13 to -0.74; P = 0.031) was also independently associated with LVMi.
CONCLUSIONS: Other than anemia, hypoalbuminemia and arterial pulse pressure, this study demonstrates an important, novel association between the degree of RRF and severity of LVH in ESRF patients undergoing long-term CAPD. Prospective studies are needed to define if indeed there is a cause-effect relationship between this association, to evaluate if a decline in residual GFR is independently associated with an increase in LVMi, and to determine whether treatment directed at preserving RRF will reduce the severity of LVH, improve cardiac performance and hence survival of these patients.

Entities:  

Mesh:

Year:  2002        PMID: 12110029     DOI: 10.1046/j.1523-1755.2002.00471.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  43 in total

1.  Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients.

Authors:  E Lars Penne; Neelke C van der Weerd; Muriel P C Grooteman; Albert H A Mazairac; Marinus A van den Dorpel; Menso J Nubé; Michiel L Bots; Renée Lévesque; Piet M ter Wee; Peter J Blankestijn
Journal:  Clin J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 8.237

2.  Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.

Authors:  Nick W Liu; Kiranpreet Khurana; Sunil Sudarshan; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2010-03-17       Impact factor: 7.450

3.  The importance of residual renal function in peritoneal dialysis.

Authors:  Dorota Sikorska; Krzysztof Pawlaczyk; Anna Olewicz-Gawlik; Natasza Czepulis; Bartlomiej Posnik; Ewa Baum; Maria Wanic-Kossowska; Bengt Lindholm; Andrzej Oko
Journal:  Int Urol Nephrol       Date:  2016-10-12       Impact factor: 2.370

4.  Determinants of left ventricular mass in patients on hemodialysis: Frequent Hemodialysis Network (FHN) Trials.

Authors:  Christopher T Chan; Tom Greene; Glenn M Chertow; Alan S Kliger; John B Stokes; Gerald J Beck; John T Daugirdas; Peter Kotanko; Brett Larive; Nathan W Levin; Ravindra L Mehta; Michael Rocco; Javier Sanz; Brigitte M Schiller; Phillip C Yang; Sanjay Rajagopalan
Journal:  Circ Cardiovasc Imaging       Date:  2012-02-23       Impact factor: 7.792

5.  Estimating residual kidney function in dialysis patients without urine collection.

Authors:  Tariq Shafi; Wieneke M Michels; Andrew S Levey; Lesley A Inker; Friedo W Dekker; Raymond T Krediet; Tiny Hoekstra; George J Schwartz; John H Eckfeldt; Josef Coresh
Journal:  Kidney Int       Date:  2016-01-21       Impact factor: 10.612

Review 6.  Infrequent dialysis: a new paradigm for hemodialysis initiation.

Authors:  Connie M Rhee; Mark Unruh; Jing Chen; Csaba P Kovesdy; Phillip Zager; Kamyar Kalantar-Zadeh
Journal:  Semin Dial       Date:  2013-09-09       Impact factor: 3.455

7.  Cardiac, Inflammatory and Metabolic Parameters: Hemodialysis versus Peritoneal Dialysis.

Authors:  Silvia Lai; Alessio Molfino; Gaspare Elios Russo; Massimo Testorio; Alessandro Galani; Georgie Innico; Nicla Frassetti; Valentina Pistolesi; Santo Morabito; Filippo Rossi Fanelli
Journal:  Cardiorenal Med       Date:  2014-12-13       Impact factor: 2.041

8.  The mini-PET in pediatric peritoneal dialysis: a useful tool to predict volume overload?

Authors:  Francisco Cano; Angelica Rojo; Marta Azocar; Maria Jose Ibacache; Angela Delucchi; Francisca Ugarte; Carlos Irarrazabal; Iris Delgado
Journal:  Pediatr Nephrol       Date:  2013-03-15       Impact factor: 3.714

9.  Extracellular volume expansion and the preservation of residual renal function in Korean peritoneal dialysis patients: a long-term follow up study.

Authors:  Harin Rhee; Min Ja Baek; Hyun Chul Chung; Jong Man Park; Woo Jin Jung; Soo Min Park; Jang Won Lee; Min Ji Shin; Il Young Kim; Sang Heon Song; Dong Won Lee; Soo Bong Lee; Ihm Soo Kwak; Eun Young Seong
Journal:  Clin Exp Nephrol       Date:  2015-11-26       Impact factor: 2.801

10.  Is valvular calcification a part of the missing link between residual kidney function and cardiac hypertrophy in peritoneal dialysis patients?

Authors:  Angela Yee-Moon Wang; Christopher Wai-Kei Lam; Mei Wang; Iris Hiu-Shuen Chan; Siu-Fai Lui; John E Sanderson
Journal:  Clin J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.